Drug-Resistant EGFR May Have “Achilles Heel”

Researchers from Yale University have discovered a key structural difference in the drug-resistant form of EGFR that could lead to new strategies to combat the disease. Drugs introduced more than a decade ago that target mutations in a protein known as the epidermal growth factor receptor (EGFR) held the promise of personalized treatments for a […]
The post Drug-Resistant EGFR May Have “Achilles Heel” appeared first on SciTech Daily.